Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of cre recombinase

被引:29
作者
Brooks, AI
Muhkerjee, B
Panahian, N
CorySlechta, D
Federoff, HJ
机构
[1] UNIV ROCHESTER, MED CTR, DEPT MICROBIOL & IMMUNOL, ROCHESTER, NY 14642 USA
[2] UNIV ROCHESTER, MED CTR, DEPT NEUROL, ROCHESTER, NY 14642 USA
[3] UNIV ROCHESTER, MED CTR, DEPT NEUROBIOL & ANAT, ROCHESTER, NY 14642 USA
[4] UNIV ROCHESTER, MED CTR, DEPT MED, ROCHESTER, NY 14642 USA
关键词
NGF; cre/loxP; gene transfer; herpes virus;
D O I
10.1038/nbt0197-57
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Focal molecular genetic alteration of the intact mammalian brain will be required to elucidate gene product function in cells comprising synaptic networks. To this end, a somatic mosaic approach has been developed for the mouse whereby a dormant germline transgene is activated by the somatic delivery and expression of cre recombinase. Transgenic mice harboring a recombinational substrate, the germline-transmitted nerve growth factor excision activation transgene (NGF-XAT) were generated. Somatic delivery of virus vectors expressing cre recombinase into the brain of NGF-XAT mice resulted in regional recombination and activation of the transgene as demonstrated at the DNA level by PCR and at the protein level by both immunocytochemistry and ELISA. This approach has been used to evaluate a behavioral correlate of unilateral NGF mosaicism within the dorsal hippocampal formation. NGF-XAT mice activated by expression of cre recombinase manifest increased locomotor activity compared with NGF-XAT mice transduced by a control virus expressing Escherichia coli beta-galactosidase. These data indicate that focally increased expression of NGF in one part of a synaptic network can elicit changes in behavior presumably by altering the overall function of NGF-responsive neural circuitry. This approach should have broad application to other gene products and promises to provide the unprecedented ability to create and study discrete genetic modifications in the context of an intact adult mammal.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 23 条
[1]  
Ashburner M., 1989, DROSOPHILA LAB HDB
[2]  
BATTLEMAN DS, 1993, J NEUROSCI, V13, P941
[3]   TRANSSYNAPTIC NEURONAL LOSS INDUCED IN HIPPOCAMPAL SLICE CULTURES BY A HERPES-SIMPLEX VIRUS VECTOR EXPRESSING THE GLUR6 SUBUNIT OF THE KAINATE RECEPTOR [J].
BERGOLD, PJ ;
CASACCIABONNEFIL, P ;
ZENG, XL ;
FEDEROFF, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6165-6169
[4]   ADENOVIRUS GENE-TRANSFER CAUSES INFLAMMATION IN THE BRAIN [J].
BYRNES, AP ;
RUSBY, JE ;
WOOD, MJA ;
CHARLTON, HM .
NEUROSCIENCE, 1995, 66 (04) :1015-1024
[5]   THE LOCALIZATION OF NERVE GROWTH FACTOR-LIKE IMMUNOREACTIVITY IN THE ADULT-RAT BASAL FOREBRAIN AND HIPPOCAMPAL-FORMATION [J].
CONNER, JM ;
MUIR, D ;
VARON, S ;
HAGG, T ;
MANTHORPE, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1992, 319 (03) :454-462
[6]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[7]   EXPRESSION OF NERVE GROWTH-FACTOR INVIVO FROM A DEFECTIVE HERPES-SIMPLEX VIRUS-1 VECTOR PREVENTS EFFECTS OF AXOTOMY ON SYMPATHETIC-GANGLIA [J].
FEDEROFF, HJ ;
GESCHWIND, MD ;
GELLER, AI ;
KESSLER, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1636-1640
[8]   TRANSGENIC MICE EXPRESSING BETA-GALACTOSIDASE IN MATURE NEURONS UNDER NEURON-SPECIFIC ENOLASE PROMOTER CONTROL [J].
FORSSPETTER, S ;
DANIELSON, PE ;
CATSICAS, S ;
BATTENBERG, E ;
PRICE, J ;
NERENBERG, M ;
SUTCLIFFE, JG .
NEURON, 1990, 5 (02) :187-197
[9]   A DEFECTIVE HSV-1 VECTOR EXPRESSES ESCHERICHIA-COLI BETA-GALACTOSIDASE IN CULTURED PERIPHERAL NEURONS [J].
GELLER, AI ;
BREAKEFIELD, XO .
SCIENCE, 1988, 241 (4873) :1667-1669
[10]  
GESCHWIND M, 1994, PROVIDING PHARM ACCE, P462